We are live on ! Find out more

249 hedge funds and large institutions have $3.14B invested in Neogen in 2018 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 69 increasing their positions, 144 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

82% more call options, than puts

Call options by funds: $1.63M | Put options by funds: $891K

20% more funds holding in top 10

Funds holding in top 10: 56 (+1)

20% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 20

10% more capital invested

Capital invested by funds: $2.84B → $3.14B (+$298M)

1% more funds holding

Funds holding: 246249 (+3)

52% less repeat investments, than reductions

Existing positions increased: 69 | Existing positions reduced: 144

61.58% less ownership

Funds ownership: 243.29%181.71% (-62%)

Holders
249
Holders Change
+3
Holders Change %
+1.22%
% of All Funds
5.71%
Holding in Top 10
6
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+20%
% of All Funds
0.14%
New
24
Increased
69
Reduced
144
Closed
20
Calls
$1.63M
Puts
$891K
Net Calls
+$734K
Net Calls Change
-$129K

NEOG Hedge Fund Activity: Q1 2018 in Review

249 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in Neogen (NEOG) for Q1 2018, worth a combined $3.14B — up 10% from $2.84B a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new NEOG positions and 20 closed out — a net gain of 4 holders — while 69 added to existing stakes and 144 trimmed.

The largest buyer was Wasatch Advisors, adding an estimated $38.1M. The largest seller was Royal Bank of Canada, cutting an estimated $17.2M.

  • 249 institutional investors held Neogen (NEOG) as of Q1 2018, up from 246 in Q4 2017.
  • Funds reported $3.14B of Neogen stock for Q1 2018, up 10% quarter-over-quarter.
  • 24 funds opened new Neogen positions in Q1 2018 and 20 closed out, a net change of +4 holders.
  • The largest Neogen buyer in Q1 2018 was Wasatch Advisors, an estimated $38.1M added.
  • The largest Neogen seller in Q1 2018 was Royal Bank of Canada, an estimated $17.2M sold.

Based on aggregated 13F filings for Q1 2018.